Identification of novel osteogenic compounds by an ex-vivo sp7:luciferase zebrafish scale assay

Auld, 2004, Receptor binding assays for HTS and drug discovery Roth, 2011, Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds, Bioorg Med Chem Lett, 21, 7180, 10.1016/j.bmcl.2011.09.077 Calamini, 2012, Small-molecule proteostasis regulators for protein conformational diseases, Nat Chem Biol, 8, 185, 10.1038/nchembio.763 DiMasi, 2003, The price of innovation: new estimates of drug development costs, J Health Econ, 22, 151, 10.1016/S0167-6296(02)00126-1 Kaitin, 2010, Deconstructing the drug development process: the new face of innovation, Clin Pharmacol Ther, 87, 356, 10.1038/clpt.2009.293 Rissanen, 2010, Models and screening assays for drug discovery in osteoporosis, Expert Opin Drug Discov, 5, 1163, 10.1517/17460441.2010.532484 Eriksen, 2010, Cellular mechanisms of bone remodeling, Rev Endocr Metab Disord, 11, 219, 10.1007/s11154-010-9153-1 Uusitalo, 2001, A metaphyseal defect model of the femur for studies of murine bone healing, Bone, 28, 423, 10.1016/S8756-3282(01)00406-9 Lelovas, 2008, The laboratory rat as an animal model for osteoporosis research, Comp Med, 58, 424 Wu, 2010, Evaluation of critical size defects of mouse calvarial bone: an organ culture study, Microsc Res Tech, 73, 540 Renn, 2006, Zebrafish and medaka as models for bone research including implications regarding space-related issues, Protoplasma, 229, 209, 10.1007/s00709-006-0215-x Apschner, 2014, Pathological mineralization in a zebrafish enpp1 mutant exhibits features of Generalized Arterial Calcification of Infancy (GACI) and Pseudoxanthoma Elasticum (PXE), Dis Model Mech, 7, 811 Mitchell, 2013, New tools for studying osteoarthritis genetics in zebrafish, Osteoarthr Cartil, 21, 269, 10.1016/j.joca.2012.11.004 To, 2012, Rankl-induced osteoclastogenesis leads to loss of mineralization in a medaka osteoporosis model, Development, 139, 141, 10.1242/dev.071035 Witten, 2001, Features of mono- and multinucleated bone resorbing cells of the zebrafish (Danio rerio) and their contribution to skeletal development, remodeling, and growth, J Morphol, 250, 197, 10.1002/jmor.1065 Fleming, 2005, High-throughput in vivo screening for bone anabolic compounds with zebrafish, J Biomol Screen, 10, 823, 10.1177/1087057105279952 Metz, 2012, Elasmoid scales of fishes as model in biomedical bone research, J Appl Ichthyol, 28, 382, 10.1111/j.1439-0426.2012.01990.x de Vrieze, 2014, Arachidonic acid enhances turnover of the dermal skeleton: studies on zebrafish scales, PLoS One, 9, e89347, 10.1371/journal.pone.0089347 de Vrieze, 2014, Prednisolone induces osteoporosis-like phenotype in regenerating zebrafish scales, Osteoporos Int, 25, 567, 10.1007/s00198-013-2441-3 Metz, 2014, Zebrafish (Danio rerio) in calcium-poor water mobilise calcium and phosphorus from scales, J Appl Ichthyol, 671, 10.1111/jai.12513 Flik, 1986, Effects of low ambient calcium levels on wholebody Ca2+ flux rates and internal calcium pools in the freshwater cichlid teleost, Oreochromis mossambicus, J Exp Biol, 120, 249, 10.1242/jeb.120.1.249 Persson, 1994, Estradiol-17β-induced calcium uptake and resorption in juvenile rainbow trout, Oncorhynchus mykiss, Fish Physiol Biochem, 379, 10.1007/BF00003417 Redruello, 2005, Isolation and characterization of piscine osteonectin and downregulation of its expression by PTH-related protein, J Bone Miner Res, 20, 682, 10.1359/JBMR.041201 Rotllant, 2005, Calcium mobilization from fish scales is mediated by parathyroid hormone related protein via the parathyroid hormone type 1 receptor, Regul Pept, 132, 33, 10.1016/j.regpep.2005.08.004 Yoshikubo, 2005, Osteoblastic activity and estrogenic response in the regenerating scale of goldfish, a good model of osteogenesis, Life Sci, 76, 2699, 10.1016/j.lfs.2004.10.063 Suzuki, 2011, Parathyroid hormone 1 (1–34) acts on the scales and involves calcium metabolism in goldfish, Bone, 48, 1186, 10.1016/j.bone.2011.02.004 Nakashima, 2002, The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation, Cell, 108, 17, 10.1016/S0092-8674(01)00622-5 Matsubara, 2008, BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation, J Biol Chem, 283, 29119, 10.1074/jbc.M801774200 Baron, 2012, Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives, J Clin Endocrinol Metab, 97, 311, 10.1210/jc.2011-2332 Westerfield, 2010 Vandesompele, 2002, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol, 3, 10.1186/gb-2002-3-7-research0034 Spoorendonk, 2008, Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton, Development, 135, 3765, 10.1242/dev.024034 Renn, 2009, Osterix-mCherry transgenic medaka for in vivo imaging of bone formation, Dev Dyn, 238, 241, 10.1002/dvdy.21836 Suster, 2009, Transgenesis in zebrafish with the Tol2 transposon system, 41 Pombinho, 2004, Development of two bone-derived cell lines from the marine teleost Sparus aurata; evidence for extracellular matrix mineralization and cell-type-specific expression of matrix Gla protein and osteocalcin, Cell Tissue Res, 315, 393, 10.1007/s00441-003-0830-1 Ignovski, 2004, Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells, Biotechnol Bioeng, 86, 827, 10.1002/bit.20059 Lang, 2006 Koumans, 1996, An in vitro, serum-free organ culture technique for the study of development and growth of the dermal skeleton in fish, In Vitro Cell Dev Biol Anim, 32, 612, 10.1007/BF02724046 Suzuki, 2000, Suppression of osteoclastic activities by calcitonin in the scales of goldfish (freshwater teleost) and nibbler fish (seawater teleost), Peptides, 21, 115, 10.1016/S0196-9781(99)00181-3 Pasqualetti, 2012, The zebrafish scale as model to study the bone mineralization process, J Mol Histol, 43, 589, 10.1007/s10735-012-9425-z de Vrieze, 2010, ALP, TRAcP and cathepsin K in elasmoid scales: a role in mineral metabolism?, J Appl Ichthyol, 26, 210, 10.1111/j.1439-0426.2010.01407.x Rawadi, 2003, BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop, J Bone Miner Res, 18, 1842, 10.1359/jbmr.2003.18.10.1842 Enders, 2009, Wnt therapy for bone loss: golden goose or Trojan horse?, J Clin Invest, 119, 758, 10.1172/JCI38973 McClung, 2014, Romosozumab in postmenopausal women with low bone mineral density, N Engl J Med, 370, 412, 10.1056/NEJMoa1305224 Dijke ten, 2008, Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling, J Bone Joint Surg, 90, 31, 10.2106/JBJS.G.01183 Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta, Endocrinology, 139, 4252, 10.1210/endo.139.10.6216 Yamaguchi, 2009, The estrogen 17beta-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-kappaB activity, Int J Mol Med, 23, 297 Banu, 2012, Alternative therapies for the prevention and treatment of osteoporosis, Nutr Rev, 70, 22, 10.1111/j.1753-4887.2011.00451.x Bellingham, 2011, A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?, CNS Neurosci Ther, 17, 4, 10.1111/j.1755-5949.2009.00116.x Chenu, 1998, Glutamate receptors are expressed by bone cells and are involved in bone resorption, Bone, 22, 295, 10.1016/S8756-3282(97)00295-0 Genever, 2001, Regulation of spontaneous glutamate release activity in osteoblastic cells and its role in differentiation and survival: evidence for intrinsic glutamatergic signaling in bone, FASEB J, 15, 1586, 10.1096/fj.00-0594fje Brakspear, 2012, Glutamate signaling in bone, Front Endocrinol, 3, 97 Chellaiah, 2009, Activation of Src kinase by protein–tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein–tyrosine phosphatase inhibitor on Src activation in vitro, J Cell Physiol, 220, 382, 10.1002/jcp.21777 Lee, 2012, Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway, Eur J Pharmacol, 676, 26, 10.1016/j.ejphar.2011.12.001 Chen, 2009, The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling, Biochemistry, 48, 10267, 10.1021/bi9009677 Hatta, 2006, Molecular characterization of the zinc finger transcription factor, osterix, Int J Mol Med, 17, 425